Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Guides ARVD recognition in SCD-prone patients; leaves open prospective validation of risk-stratification tools.
In Brief Arrhythmogenic right ventricular dysplasia (ARVD) is one of the most common causes of sudden cardiac death in the United States. There have been many significant advances in the understanding of ARVD, although much information remains unknown. Due to the high rate of death from this disease, understanding the epidemiology, etiology, diagnosis, presentation, treatment, and areas of current and future research is essential.
No takes yet. Share an insight, caveat, or question.
Wolfe et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: